HopeStage
Back to all studies
RecruitingNCT06860165

App-based mood monitoring for adults with depression

About this titleRead the official source — NCT06860165
Observational studyAges 18+France
The study in practice

Understand this study

Who could participate?

This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.

Listed locations
Changé and 1 more locationSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: July 15, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
98
Sponsor
Emobot
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
Interview / survey / observational
Study phase
Not clearly listed
Locations
France
Age range
Over 18 Years
Official registry ID
NCT06860165
Official title
Show the full official title

Validation of EmoDTx as a Digital Endpoint for Mood Monitoring in Adult Patients With Unipolar Depression: An Observational Study Against Standard Depression Assessment Questionnaires

Recruitment & locations

Recruiting

Changé · Nîmes

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Emobot.

Who can participate?

This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies